An updated review of quality-of-life questionnaires for urinary incontinence and overactive bladder: Which ones to use and why
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abrams P, Kelleher CJ, Kerr LA, Rogers RG: Overactive bladder significantly affects quality of life. Am J Manag Care 2000, 6(Suppl 11):S580–590.
Abrams P, Cardozo L, Fall M, et al.: The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003, 61:37–49.
Milsom I, Abrams P, Cardozo L, et al.: How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001, 87:760–766.
Stewart WF, Van Rooyen JB, Cundiff GW, et al.: Prevalence and burden of overactive bladder in the United States. World J Urol 2003, 20:327–336.
Minassian VA, Drutz HP, Al-Badr A: Urinary incontinence as a worldwide problem. Int J Gynaecol Obstet 2003, 82:327–338.
Boyle P, Robertson C, Mazzetta C, et al.: The prevalence of male urinary incontinence in four centres: the UREPIK study. BJU Int 2003, 92:943–947.
Leidy NK, Revicki DA, Geneste B: Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health 1999, 2:113–127.
Patrick DL, Chiang YP: Measurement of health outcomes in treatment effectiveness evaluations: Conceptual and methodological challenges. Med Care 2000, 38(Suppl 9):II14–25.
Dugan E, Cohen SJ, Robinson D, et al.: The quality of life of older adults with urinary incontinence: determining generic and condition-specific predictors. Qual Life Res 1998, 7:337–344.
Wiebe S, Guyatt G, Weaver B, et al.: Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol 2003, 56:52–60.
Matza LS, Zyczynski TM, Bavendam T: A review of quality of life questionnaires for urinary incontinence and overactive bladder: which ones to use and why. Curr Urol Rep 2004, 5:336–342.
Guyatt GH, Feeny DH, Patrick DL: Measuring health-related quality of life. Ann Intern Med 1993, 118:622–629.
Jaeschke R, Singer J, Guyatt GH: Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989, 10:407–415.
Kelleher CJ, Pleil AM, Reese PR, et al.: How much is enough and who says so? BJOG 2004, 111:605–612.
Nixon A, Colman S, Sabounjian L, et al.: A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials. J Urol 2005, 174:604–607.
Bradley CS, Rovner ES, Morgan MA, et al.: A new questionnaire for urinary incontinence diagnosis in women: development and testing. Am J Obstet Gynecol 2005, 192:66–73.
Jackson S, Donovan J, Brookes S, et al.: The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing. Br J Urol 1996, 77:805–812.
Coyne K, Margolis MK, Zyczynski T, et al.: Validation of an OAB screener in a primary care patient population in the US. Neurourol Urodyn 2004, 23:531–532.
Abrams P, Avery K, Gardener N, Donovan J: The international consultation on Incontinence Modular Questionnaire: www.iciq.net. J Urol 2006, 175:1063–1066.
Amarenco G, Arnould B, Carita P, et al.: European psychometric validation of the CONTILIFE: a quality of life questionnaire for urinary incontinence. Eur Urol 2003, 43:391–404.
Darai E, Jeffry L, Deval B, et al.: Results of tension-free vaginal tape in patients with or without vaginal hysterectomy. Eur J Obstet Gynecol Reprod Biol 2002, 103:163–167.
Jeffry L, Deval B, Birsan A, et al.: Objective and subjective cure rates after tension-free vaginal tape for treatment of urinary incontinence. Urology 2001, 58:702–706.
Roumeguere T, Quackels T, Bollens R, et al.: Trans-obturator vaginal tape (TOT) for female stress incontinence: one year follow-up in 120 patients. Eur Urol 2005, 48:805–809.
Shumaker SA, Wyman JF, Uebersax JS, et al.: Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program in Women (CPW) Research Group. Qual Life Res 1994, 3:291–306.
Harvey MA, Kristjansson B, Griffith D, Versi E: The Incontinence Impact Questionnaire and the Urogenital Distress Inventory: a revisit of their validity in women without a urodynamic diagnosis. Am J Obstet Gynecol 2001, 185:25–31.
Handa VL, Massof RW: Measuring the severity of stress urinary incontinence using the Incontinence Impact Questionnaire. Neurourol Urodyn 2004, 23:27–32.
van der Vaart CH, de Leeuw JR, Roovers JP, Heintz AP: Measuring health-related quality of life in women with urogenital dysfunction: the urogenital distress inventory and incontinence impact questionnaire revisited. Neurourol Urodyn 2003, 22:97–104.
Gray M, Wyman J: Is the Incontinence Impact Questionnaire Short Form (IIQ-7) a clinically useful tool for WOC nursing practice? J Wound Ostomy Continence Nurs 2004, 31:317–324.
Robinson D, Pearce KF, Preisser JS, et al.: Relationship between patient reports of urinary incontinence symptoms and quality of life measures. Obstet Gynecol 1998, 91:224–228.
Uebersax JS, Wyman JF, Shumaker SA, et al.: Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourol Urodyn 1995, 14:131–139.
Robinson JP, Shea JA: Development and testing of a measure of health-related quality of life for men with urinary incontinence. J Am Geriatr Soc 2002, 50:935–945.
Del Priore G, Taylor SY, Esdaile BA, et al.: Urinary incontinence in gynecological oncology patients. Int J Gynecol Cancer 2005, 15:911–914.
Teunissen D, van Weel C, Lagro-Janssen T: Urinary incontinence in older people living in the community: examining help-seeking behaviour. Br J Gen Pract 2005, 55:776–782.
Dmochowski RR, Sand PK, Zinner NR, et al.: Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence. Urology 2003, 62:237–242.
Rapp DE, Lucioni A, Katz EE, et al.: Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience. Urology 2004, 63:1071–1075.
Richter HE, Norman AM, Burgio KL, et al.: Tension-free vaginal tape: a prospective subjective and objective outcome analysis. Int Urogynecol J Pelvic Floor Dysfunct 2005, 16:109–113.
Schraffordt Koops SE, Bisseling TM, Heintz AP, Vervest HA: Quality of life before and after TVT, a prospective multicentre cohort study, results from the Netherlands TVT database. BJOG 2006, 113:26–29.
Patrick DL, Martin ML, Bushnell DM, et al.: Quality of life of women with urinary incontinence: further development of the incontinence quality of life instrument (I-QOL). Urology 1999, 53:71–76.
Wagner TH, Patrick DL, Bavendam TG, et al.: Quality of life of persons with urinary incontinence: development of a new measure. Urology 1996, 47:67–72.
Bump RC, Norton PA, Zinner NR, Yalcin I: Mixed urinary incontinence symptoms: urodynamic findings, incontinence severity, and treatment response. Obstet Gynecol 2003, 102:76–83.
Melville JL, Miller EA, Fialkow MF, et al.: Relationship between patient report and physician assessment of urinary incontinence severity. Am J Obstet Gynecol 2003, 189:76–80.
Oh SJ, Hong SK, Son H, et al.: Quality of life and disease severity in Korean women with stress urinary incontinence. Urology 2005, 66:69–73.
I-QOL [Online]. Available at http://www.proqolid.org/. Accessed June 21, 2006.
Bushnell DM, Martin ML, Summers KH, et al.: Quality of life of women with urinary incontinence: cross-cultural performance of 15 language versions of the I-QOL. Qual Life Res 2005, 14:1901–1913.
Yalcin I, Bump RC: Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol 2003, 189:98–101.
Yu LC, Kaltreider DL, Hu T, et al.: The ISQ-P tool: measuring stress associated with incontinence. J Gerontol Nurs 1989, 15:9–15.
Komatsu H, Kojima M, Suzuki K, et al.: [Development of a questionnaire to measure the effect of urinary incontinence on female sexuality: a reliability and validity study]. Kango Kenkyu 1996, 29:386–398.
Kelleher CJ, Cardozo LD, Khullar V, Salvatore S: A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 1997, 104:1374–1379.
Badia Llach X, Castro Diaz D, Conejero Sugranes J: [Validity of the King’s Health questionnaire in the assessment of quality of life of patients with urinary incontinence. The King’s Group]. Med Clin (Barc) 2000, 114:647–652.
Kobelt G, Kirchberger I, Malone-Lee J: Review. Quality-of-life aspects of the overactive bladder and the effect of treatment with tolterodine. BJU Int 1999, 83:583–590.
Reese PR, Pleil AM, Okano GJ, Kelleher CJ: Multinational study of reliability and validity of the King’s Health Questionnaire in patients with overactive bladder. Qual Life Res 2003, 12:427–442.
Tamanini JT, Dambros M, D’Ancona CA, et al.: Concurrent validity, internal consistency and responsiveness of the Portuguese version of the King’s Health Questionnaire (KHQ) in women after stress urinary incontinence surgery. Int Braz J Urol 2004, 30:479–486.
Uemura S, Homma Y: Reliability and validity of King’s Health Questionnaire in patients with symptoms of overactive bladder with urge incontinence in Japan. Neurourol Urodyn 2004, 23:94–100.
Bjelic-Radisic V, Dorfer M, Tamussino K, Greimel E: Psychometric properties and validation of the German-language King’s Health Questionnaire in women with stress urinary incontinence. Neurourol Urodyn 2005, 24:63–68.
Conway K, Uzun V, Marrel A, et al.: Linguistic validation of the King’s Health Questionnaire (KHQ) in eight languages. Value Health 1999, 2:204.
Kochakarn W, Pummangura N, Kijvikai K, et al.: Reliability of a Thai version of King’s Health Questionnaire in Thai females with overactive bladder symptoms. J Med Assoc Thai 2005, 88:1526–1534.
Oh SJ, Park HG, Paick SH, et al.: Translation and linguistic validation of Korean version of the King’s Health Questionnaire instrument. Koren J Urol 2005, 46:438–450.
Okamura K, Usami T, Nagahama K, et al.: ‘Quality of life’ assessment of urination in elderly Japanese men and women with some medical problems using International Prostate Symptom Score and King’s Health Questionnaire. Eur Urol 2002, 41:411–419.
Deval B, Ferchaux J, Berry R, et al.: Objective and subjective cure rates after trans-obturator tape (OBTAPE) treatment of female urinary incontinence. Eur Urol 2006, 49(2):373–377.
Homma Y, Kawabe K: Health-related quality of life of Japanese patients with overactive bladder treated with extended-release tolterodine or immediate-release oxybutynin: a randomized, placebo-controlled trial. World J Urol 2004, 22:251–256.
Kelleher CJ, Kreder KJ, Pleil AM, et al.: Long-term health-related quality of life of patients receiving extended-release tolterodine for overactive bladder. Am J Manag Care 2002, 8(Suppl 19):S616–630.
Kelleher CJ, Reese PR, Pleil AM, Okano GJ: Health-related quality of life of patients receiving extended-release tolterodine for overactive bladder. Am J Manag Care 2002, 8(Suppl 19):S608–615.
Kelleher CJ, Cardozo L, Chapple CR, et al.: Improved quality of life in patients with overactive bladder symptoms treated with solifenacin. BJU Int 2005, 95:81–85.
Quarto G, Autorino R, Gallo A, et al.: Quality of life in women with multiple sclerosis and overactive bladder syndrome. Int Urogynecol J Pelvic Floor Dysfunct 2006. Available at http://www.springerlink.com/link.asp?id=75546414tp445713.
Rajkumar GN, Small DR, Mustafa AW, Conn G: A prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity. BJU Int 2005, 96:848–852.
Coyne KS, Matza LS, Kopp Z, Abrams P: The validation of the Patient Perception of Bladder Condition (PPBC): a single-item global measure for patients with overactive bladder. Eur Urol 2006, 49:1079–1086.
Pleil AM, Coyne KS, Reese PR, et al.: The validation of patient-rated global assessments of treatment benefit, satisfaction, and willingness to continue—the BSW. Value Health 2005, 8(Suppl 1):S25–34.
Tamanini JT, Dambros M, D’Ancona CA, et al.: [Validation of the ‘International Consultation on Incontinence Questionnaire—Short Form’ (ICIQ-SF) for Portuguese]. Rev Saude Publica 2004, 38:438–444.
Wild DJ, Clayson DJ, Keating K, Gondek K: Validation of a patient-administered questionnaire to measure the activity impairment experienced by women with uncomplicated urinary tract infection: the Activity Impairment Assessment (AIA). Health Qual Life Outcomes 2005, 3:42.
Homma Y, Uemura S: Use of the short form of King’s Health Questionnaire to measure quality of life in patients with an overactive bladder. BJU Int 2004, 93:1009–1013.
Shaw C, Matthews RJ, Perry SI, et al.: Validity and reliability of a questionnaire to measure the impact of lower urinary tract symptoms on quality of life: the Leicester Impact Scale. Neurourol Urodyn 2004, 23:229–236.
Abraham L, Hareendran A, Mills IW, et al.: Development and validation of a quality-of-life measure for men with nocturia. Urology 2004, 63:481–486.
Coyne KS, Schmier J, Hunt T, et al.: Developing a specific HRQL instrument for overactive bladder. Value Health 2000, 3:141.
Coyne K, Revicki D, Hunt T, et al.: Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res 2002, 11:563–574.
Coyne KS, Matza LS, Thompson C: The responsiveness of the Overactive Bladder Questionnaire (OAB-q). Qual Life Res 2005, 14:819–825.
Coyne KS, Matza LS, Thompson C, et al.: Determining the importance of change in the OAB-q. J Urol 2006, 176:627–632.
Matza LS, Thompson CL, Krasnow J, et al.: Test-retest reliability of four questionnaires for patients with overactive bladder: The overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ). Neurourol Urodyn 2005, 24:215–225.
Coyne KS, Zhou Z, Bhattacharyya SK, et al.: The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA. BJU Int 2003, 92:948–954.
Coyne KS, Zhou Z, Thompson C, Versi E: The impact on health-related quality of life of stress, urge and mixed urinary incontinence. BJU Int 2003, 92:731–735.
Acquadro C, Kopp Z, Coyne KS, et al.: Translating overactive bladder questionnaires in 14 languages. Urology 2006, 67:536–540.
Overactive Bladder Questionnaire Family [Online]. Available at: http://www.oabq.com. Accessed June 21, 2006.
Chapple CR, Martinez-Garcia R, Selvaggi L, et al.: A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial. Eur Urol 2005, 48:464–470.
Marquis P, Amarenco G, Sapede C, et al.: Development and validation of a disease-specific quality of life questionnaire for urinary urge incontinency. Qual Life Res 1995, 4:458–459.
Costa P, Perrouin-Verbe B, Colvez A, et al.: Quality of life in spinal cord injury patients with urinary difficulties. Development and validation of qualiveen. Eur Urol 2001, 39:107–113.
Bonniaud V, Jackowski D, Parratte B, et al.: Quality of life in multiple sclerosis patients with urinary disorders: discriminative validation of the English version of Qualiveen. Qual Life Res 2005, 14:425–431.
Mitsui T, Morita H, Koyanagi T: Quality of life for urinary management in spinal cord injury patients [abstract]. BJU Int 2002, 90(Suppl 2):250.
Vastenholt JM, Snoek GJ, Buschman HP, et al.: A 7-year follow-up of sacral anterior root stimulation for bladder control in patients with a spinal cord injury: quality of life and users’ experiences. Spinal Cord 2003, 41:397–402.
Black N, Griffiths J, Pope C: Development of a symptom severity index and a symptom impact index for stress incontinence in women. Neurourol Urodyn 1996, 15:630–640.
Chen GD, Lin TL, Hu SW, et al.: Prevalence and correlation of urinary incontinence and overactive bladder in Taiwanese women. Neurourol Urodyn 2003, 22:109–117.
Stach-Lempinen B, Kujansuu E, Laippala P, Metsanoja R: Visual analogue scale, urinary incontinence severity score and 15 D—psychometric testing of three different health-related quality-of-life instruments for urinary incontinent women. Scand J Urol Nephrol 2001, 35:476–483.
Parkkinen A, Karjalainen E, Vartiainen M, Penttinen J: Physiotherapy for female stress urinary incontinence: individual therapy at the outpatient clinic versus home-based pelvic floor training: a 5-year follow-up study. Neurourol Urodyn 2004, 23:643–648.
Valpas A, Kivela A, Penttinen J, et al.: Tension-free vaginal tape and laparoscopic mesh colposuspension for stress urinary incontinence. Obstet Gynecol 2004, 104:42–49.
Stach-Lempinen B, Hakala AL, Laippala P, et al.: Severe depression determines quality of life in urinary incontinent women. Neurourol Urodyn 2003, 22:563–568.
Slack M, Culligan P, Tracey M, et al.: Relationship of urethral retro-resistance pressure to urodynamic measurements and incontinence severity. Neurourol Urodyn 2004, 23:109–114.
Stach-Lempinen B, Kirkinen P, Laippala P, et al.: Do objective urodynamic or clinical findings determine impact of urinary incontinence or its treatment on quality of life? Urology 2004, 63:67–72.
DuBeau CE, Kiely DK, Resnick NM: Quality of life impact of urge incontinence in older persons: a new measure and conceptual structure. J Am Geriatr Soc 1999, 47:989–994.
Brown JS, Posner SF, Stewart AL: Urge incontinence: new health-related quality of life measures. J Am Geriatr Soc 1999, 47:980–988.
Lubeck DP, Prebil LA, Peeples P, Brown JS: A health related quality of life measure for use in patients with urge urinary incontinence: a validation study. Qual Life Res 1999, 8:337–344.
Rai GS, Kiniors M, Wientjes H: Urinary incontinence handicap inventory. Arch Gerontol Geriatr 1994, 19:7–10.
Lee PS, Reid DW, Saltmarche A, Linton L: Measuring the psychosocial impact of urinary incontinence: the York Incontinence Perceptions Scale (YIPS). J Am Geriatr Soc 1995, 43:1275–1278.